Related Experiment Video
Updated: Jul 11, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Development of Prediction Model for Mean Parotid Dose of HNC Undergoing Radiotherapy - A Single Institutional Study
Soumen Bera1, Dipika Choudhury1, Sanjoy Roy1
1Department of Radiation Oncology, Ruby General Hospital, Kolkata, West Bengal, India.
A new prediction model for head-and-neck cancer (HNC) radiotherapy accurately estimates mean parotid dose. This model helps optimize treatment plans, minimizing radiation toxicity and improving planning efficiency for HNC patients.
Area of Science:
- Radiation Oncology
- Medical Physics
- Head and Neck Cancer Treatment
Background:
- Head-and-neck cancer (HNC) patients undergoing radiotherapy require careful planning to spare organs at risk, particularly the parotid glands.
- Accurate prediction of mean parotid dose is crucial for minimizing xerostomia and other radiation-induced toxicities.
- Existing methods may not always be efficient or precise in optimizing dose distribution for parotid glands.
Purpose of the Study:
- To develop a simple prediction model for estimating the mean parotid dose in HNC patients.
- To utilize previous treatment plans to create a predictive tool for radiotherapy planning.
- To improve the efficiency and accuracy of dose sparing for parotid glands during HNC treatment.
Main Methods:
- Developed and compared two prediction models (linear regression and exponential) using data from 95 HNC patients treated with VMAT.
- The predictor variable used was fractional overlapping parotid volume with the planning target volume (PTV) plus a 2 mm margin.
- Statistical analysis included outlier exclusion, R-squared, root-mean-square error calculation, and Shapiro-Wilk test for residual normality.
Main Results:
- Both linear and exponential models showed strong predictive capabilities, with R-squared values of 0.85 and 0.82, respectively.
- The models predicted a mean parotid dose of 26 Gy with fractional overlaps of 16.4% (linear) and 18.9% (exponential).
- Prospective implementation in 12 patients demonstrated significant improvements in minimizing dose to the parotid glands.
Conclusions:
- A simple prediction model for mean parotid dose in HNC radiotherapy was successfully developed.
- The model shows promise for assisting planners in optimizing treatment, reducing toxicity, and enhancing planning efficiency.
- Further validation with external datasets and clinical integration are recommended for future studies.
More Related Videos
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020